This perspective was written by Kristen Palma, President, TargetCancer Foundation In my life I have had the experience of being a caregiver to a loved one who...
Speak Out to Save Rare Cancer Research! There’s no such thing as a “good” cancer diagnosis. Hearing the words “you have cancer” unleashes fear, uncertainty,...
This reflection was written by TCF Volunteer and Advocate Kim Balkus. When my mom was diagnosed with cholangiocarcinoma in 2013, TargetCancer Foundation...
TCF Volunteer Abigail Linehan contributed to this webinar recap. On May 15, we were lucky to be joined by four incredible women whose advocacy is having a...
This post was written by Hetal Vig, MS, MGC, CGC, Director of Research and Clinical Engagement The 2024 NORD Breakthrough Summit focused on uniting leaders to...
This reflection was written by: Jim Palma, Chief Executive Officer Like many people in the rare cancer advocacy world, I entered my own advocacy work...
We are incredibly proud to announce that our Executive Director Jim Palma has been named a Ruesch Center 2022 Luminary Awards in GI Cancer recipient! The...
Meet TargetCancer volunteer Gleb Budilovsky! Gleb grew up in Topsfield, MA, and moved to Boston in 2005, where he lives with his wife Lindsey and adorable dog...
Meet TargetCancer Foundation volunteer Jenna Hart. Originally from Connecticut, Jenna now lives on Boston's North Shore and is the Senior Visual Designer on...
Written by Kristen Palma, TargetCancer Foundation President Each year, as I sit down to write this note, I wonder what more I can say. It has been 13...
We are pleased to introduce you to TargetCancer Foundation's newest volunteer, Giselle Mota. Originally from Los Angeles, CA, Giselle currently resides in...
Originally from Dalton, MA, Catherine moved to the Boston area in 2020 after graduating from Williams College. She is a Senior Practice Coordinator at Mintz....
As the 2022 TargetCancer Foundation Gala approaches, we are pleased to feature some of our wonderful volunteers, whose efforts are integral to the Gala's...
An exciting paper was recently published in Cancer Discovery highlighting the promise of the recently FDA approved FGFR inhibitor drugs for an even broader...
Today TargetCancer Foundation remembers our founder, Paul Poth, whose life was taken by cholangiocarcinoma at age 39 on this day ten years ago- August 22,...